Dr. Samer Hussein is a researcher at the CHU Research Centre of Quebec – Laval University, and is part of the St-Patrick group of research in fundamental oncology. He is also Assistant Professor in the Department of Molecular Biology, Medical Biochemistry and Pathology of the Faculty of Medicine, Laval University.
His research aims to understand the molecular mechanisms that establish and regulate pluripotent cell states, particularly the role of long non-coding RNAs in gene networks, as well as the transcriptional events responsible for cancer initiation and progression.
Defining gene networks and their interactions that govern pluripotent states
Pluripotency is defined as the ability of a cell to generate all the cell types found in an organism. The three transcription factors Oct4, Sox2, and Nanog represent the central pillars of the gene regulatory network associated with the maintenance of a pluripotent state. Through cellular models of pluripotency and reprogramming, and the use of high-throughput technologies (proteomics, RNA-seq and ChIP-seq), this project aims to understand how interactions between transcription factors of pluripotency and chromatin regulators determine cell fate and cell transition to specific lineages in embryonic development, as well as cancer development.
Defining the role of certain long non-coding RNAs in cell identity
Long non-coding RNAs (lncRNA) constitute an entire class of RNA, characterized by the fact that they do not encode any known protein and that they are composed of at least 200 base pairs. LncRNAs are implicated in gene regulation and maintenance of cellular identity, but their mechanism of action involved in the establishment of pluripotency remains unknown. The objective of this project is to understand the role of lncRNAs in the regulation of pluripotent states and the reprogramming of embryonic stem cells.
9, rue McMahon
2779
Québec, Québec
Canada G1R 3S3
Latest news
- [Université Laval] Découverte d’une enzyme protectrice contre l’anémie de Fanconi 2023-03-08
- [ULaval Nouvelles] Cancer de la prostate : des avancées du côté de la résistance aux traitements hormonaux 2022-12-05
- L’événement « Ensemble, nous pouvons le vaincre! » permet de recueillir 28 000$ pour la recherche contre le cancer 2019-10-18
Long non-coding RNAs and transposable elements: A functional relationship
Journal ArticleBiochim Biophys Acta Mol Cell Res, 1868 (1), 2021.
Pan-cancer analysis of non-coding transcripts reveals the prognostic onco-lncRNA HOXA10-AS in gliomas
Journal ArticleCell Rep, 37 (3), 2021.
A New View of Genome Organization Through RNA Directed Interactions
Journal ArticleFront Cell Dev Biol, 8 , 2020.
Intermittent fasting promotes adipose thermogenesis and metabolic homeostasis via VEGF-mediated alternative activation of macrophage
Journal ArticleCell Res, 27 (11), 2017.
Irx3 is required for postnatal maturation of the mouse ventricular conduction system
Journal ArticleSci Rep, 6 , 2016.
CD24 tracks divergent pluripotent states in mouse and human cells
Journal ArticleNat Commun, 6 , 2015.
An epigenomic roadmap to induced pluripotency reveals DNA methylation as a reprogramming modulator
Journal ArticleNat Commun, 5 , 2014.
Small RNA changes en route to distinct cellular states of induced pluripotency
Journal ArticleNat Commun, 5 , 2014.
Proteome adaptation in cell reprogramming proceeds via distinct transcriptional networks
Journal ArticleNat Commun, 5 , 2014.
Local acting Sticky-trap inhibits vascular endothelial growth factor dependent pathological angiogenesis in the eye
Journal ArticleEMBO Mol Med, 6 (5), 2014.
Active projects
- Direct lineage reprogramming of astrocytes to new oligodendrocytes for the treatment of demyelinating disease, from 2022-04-01 to 2026-01-31
- Exploration des interactions fonctionnelles des longs ARNs non-codants dans le développement embryonnaire et le cancer, from 2022-07-01 to 2025-06-30
- Implications of RNA isoform diversity on gene function and cellular plasticity, from 2024-04-01 to 2029-03-31
- Targeting the sonic hedgehog medulloblastoma metabolic program for therapeutic purposes, from 2024-09-01 to 2026-08-31
- Unraveling the functional domains of a novel pluripotency-associated lncRNA, from 2023-04-01 to 2028-03-31
Recently finished projects
- Conférence Signalisation Québec 2022, from 2022-06-01 to 2023-05-31
- Repairing the dopaminergic circuits in Parkinson disease using synucleinopathy resistant neurones grafting, from 2022-04-01 to 2024-03-31
- Transcription factor stoichiometry defines distinct pluripotent states, from 2016-04-01 to 2023-03-31